Same Drug Class

Osimertinib vs Tofacitinib

Osimertinib vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Osimertinib and Tofacitinib.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Osimertinib — 48 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Osimertinib — C28H33N7O2; Tofacitinib — C16H20N6O.

Molecular Weight: Osimertinib — 499.6050 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Osimertinib — Small molecule; Tofacitinib — Small molecule.